BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29222071)

  • 1. HDAC11 is a regulator of diverse immune functions.
    Yanginlar C; Logie C
    Biochim Biophys Acta Gene Regul Mech; 2018 Jan; 1861(1):54-59. PubMed ID: 29222071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells.
    Cheng F; Lienlaf M; Perez-Villarroel P; Wang HW; Lee C; Woan K; Woods D; Knox T; Bergman J; Pinilla-Ibarz J; Kozikowski A; Seto E; Sotomayor EM; Villagra A
    Mol Immunol; 2014 Jul; 60(1):44-53. PubMed ID: 24747960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology.
    Sahakian E; Chen J; Powers JJ; Chen X; Maharaj K; Deng SL; Achille AN; Lienlaf M; Wang HW; Cheng F; Sodré AL; Distler A; Xing L; Perez-Villarroel P; Wei S; Villagra A; Seto E; Sotomayor EM; Horna P; Pinilla-Ibarz J
    J Leukoc Biol; 2017 Aug; 102(2):475-486. PubMed ID: 28550123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
    Villagra A; Cheng F; Wang HW; Suarez I; Glozak M; Maurin M; Nguyen D; Wright KL; Atadja PW; Bhalla K; Pinilla-Ibarz J; Seto E; Sotomayor EM
    Nat Immunol; 2009 Jan; 10(1):92-100. PubMed ID: 19011628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.
    Huang J; Wang L; Dahiya S; Beier UH; Han R; Samanta A; Bergman J; Sotomayor EM; Seto E; Kozikowski AP; Hancock WW
    Sci Rep; 2017 Aug; 7(1):8626. PubMed ID: 28819166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis infection induces IL-10 gene expression by disturbing histone deacetylase 6 and histonedeacetylase 11 equilibrium in macrophages.
    Wang X; Wu Y; Jiao J; Huang Q
    Tuberculosis (Edinb); 2018 Jan; 108():118-123. PubMed ID: 29523311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC11: a rising star in epigenetics.
    Liu SS; Wu F; Jin YM; Chang WQ; Xu TM
    Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes.
    Núñez-Álvarez Y; Suelves M
    FEBS J; 2022 May; 289(10):2771-2792. PubMed ID: 33891374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Analysis of Histone Deacetylase 11 (HDAC11).
    Chen J; Sahakian E; Powers J; Lienlaf M; Perez-Villarroel P; Knox T; Villagra A
    Methods Mol Biol; 2016; 1436():147-65. PubMed ID: 27246214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HDAC11 in obesity-related metabolic disorders: A critical review.
    Yang H; Chen L; Sun Q; Yao F; Muhammad S; Sun C
    J Cell Physiol; 2021 Aug; 236(8):5582-5591. PubMed ID: 33481312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design.
    Khatun S; Prasad Bhagat R; Dutta R; Datta A; Jaiswal A; Halder S; Jha T; Amin SA; Gayen S
    Biochem Pharmacol; 2024 Jul; 225():116312. PubMed ID: 38788962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.
    Sahakian E; Powers JJ; Chen J; Deng SL; Cheng F; Distler A; Woods DM; Rock-Klotz J; Sodre AL; Youn JI; Woan KV; Villagra A; Gabrilovich D; Sotomayor EM; Pinilla-Ibarz J
    Mol Immunol; 2015 Feb; 63(2):579-85. PubMed ID: 25155994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells.
    Wang W; Fu L; Li S; Xu Z; Li X
    Cell Biol Int; 2017 Dec; 41(12):1290-1295. PubMed ID: 28782861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of histone deacetylase inhibitors in inflammation.
    Grabiec AM; Tak PP; Reedquist KA
    Crit Rev Immunol; 2011; 31(3):233-63. PubMed ID: 21740352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC11, an emerging therapeutic target for metabolic disorders.
    Chen H; Xie C; Chen Q; Zhuang S
    Front Endocrinol (Lausanne); 2022; 13():989305. PubMed ID: 36339432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 11 inhibits interleukin 10 in B cells of subjects with allergic rhinitis.
    Shao JB; Luo XQ; Wu YJ; Li MG; Hong JY; Mo LH; Liu ZG; Li HB; Liu DB; Yang PC
    Int Forum Allergy Rhinol; 2018 Nov; 8(11):1274-1283. PubMed ID: 30007011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of histone deacetylase 11 promotes expression of IL-10 in Kupffer cells and induces tolerance following orthotopic liver transplantation in rats.
    Lian ZR; Xu YF; Wang XB; Gong JP; Liu ZJ
    J Surg Res; 2012 May; 174(2):359-68. PubMed ID: 21392795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC11: A novel target for improved cancer therapy.
    Liu Y; Tong X; Hu W; Chen D
    Biomed Pharmacother; 2023 Oct; 166():115418. PubMed ID: 37659201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylases as regulators of inflammation and immunity.
    Shakespear MR; Halili MA; Irvine KM; Fairlie DP; Sweet MJ
    Trends Immunol; 2011 Jul; 32(7):335-43. PubMed ID: 21570914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC11 regulates interleukin-13 expression in CD4+ T cells in the heart.
    Yuan L; Chen X; Cheng L; Rao M; Chen K; Zhang N; Meng J; Li M; Yang LT; Yang PC; Wang X; Song J
    J Mol Cell Cardiol; 2018 Sep; 122():1-10. PubMed ID: 30063898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.